de Kraker J - Search Results

1

Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urine.

Kaijser GP, Beijnen JH, Bult A, Wiese G, de Kraker J, Keizer HJ, Underberg WJ. Kaijser GP, et al. Among authors: de kraker j. J Chromatogr. 1992 Dec 2;583(2):175-82. doi: 10.1016/0378-4347(92)80550-a. J Chromatogr. 1992. PMID: 1478981

2

Gas chromatographic determination of ifosfamide in microvolumes of urine and plasma.

Kaijser GP, Beijnen JH, Bult A, Wiese G, de Kraker J, Underberg WJ. Kaijser GP, et al. Among authors: de kraker j. J Chromatogr. 1991 Nov 15;571(1-2):121-31. doi: 10.1016/0378-4347(91)80439-j. J Chromatogr. 1991. PMID: 1810941

3

Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma.

Kaijser GP, Beijnen JH, Jeunink EL, Bult A, Keizer HJ, de Kraker J, Underberg WJ. Kaijser GP, et al. Among authors: de kraker j. J Chromatogr. 1993 May 5;614(2):253-9. doi: 10.1016/0378-4347(93)80316-v. J Chromatogr. 1993. PMID: 8314937

4

Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography.

Kaijser GP, Ter Riet PG, de Kraker J, Bult A, Beijnen JH, Underberg WJ. Kaijser GP, et al. Among authors: de kraker j. J Pharm Biomed Anal. 1997 Mar;15(6):773-81. doi: 10.1016/s0731-7085(96)01893-6. J Pharm Biomed Anal. 1997. PMID: 9172103

5

Pharmacokinetics of ifosfamide and some metabolites in children.

Kaijser GP, De Kraker J, Bult A, Underberg WJ, Beijnen JH. Kaijser GP, et al. Among authors: de kraker j. Anticancer Res. 1998 May-Jun;18(3B):1941-9. Anticancer Res. 1998. PMID: 9677448

6

High-performance liquid chromatographic determination of stabilized 4-hydroxyifosfamide in human plasma and erythrocytes.

Kerbusch T, Huitema AD, Kettenes-van den Bosch JJ, Keizer HJ, Ouwerkerk J, de Kraker J, Beijnen JH. Kerbusch T, et al. Among authors: de kraker j. J Chromatogr B Biomed Sci Appl. 1998 Sep 25;716(1-2):275-84. doi: 10.1016/s0378-4347(98)00298-9. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9824241

7

Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Kerbusch T, de Kraker J, Keizer HJ, van Putten JW, Groen HJ, Jansen RL, Schellens JH, Beijnen JH. Kerbusch T, et al. Among authors: de kraker j. Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004. Clin Pharmacokinet. 2001. PMID: 11236809 Review.

8

Population pharmacokinetics of ifosfamide and its dechloroethylated and hydroxylated metabolites in children with malignant disease: a sparse sampling approach.

Kerbusch T, de Kraker J, Mathĵt RA, Beijnen JH. Kerbusch T, et al. Among authors: de kraker j. Clin Pharmacokinet. 2001;40(8):615-25. doi: 10.2165/00003088-200140080-00005. Clin Pharmacokinet. 2001. PMID: 11523727

9

Ifosfamide in pediatric oncology.

de Kraker J. de Kraker J. Anticancer Drugs. 1991 Aug;2(4):339-41. doi: 10.1097/00001813-199108000-00002. Anticancer Drugs. 1991. PMID: 1797190 Review.

10

Experience with ifosfamide in paediatric tumours.

de Kraker J, Voûte PA. de Kraker J, et al. Cancer Chemother Pharmacol. 1989;24 Suppl 1:S28-9. doi: 10.1007/BF00253235. Cancer Chemother Pharmacol. 1989. PMID: 2758568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters